0001213900-20-007135.txt : 20200323 0001213900-20-007135.hdr.sgml : 20200323 20200323164000 ACCESSION NUMBER: 0001213900-20-007135 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200323 DATE AS OF CHANGE: 20200323 EFFECTIVENESS DATE: 20200323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SenesTech, Inc. CENTRAL INDEX KEY: 0001680378 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 202079805 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363481 FILM NUMBER: 20735333 BUSINESS ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 BUSINESS PHONE: (928) 779 - 4143 MAIL ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 D 1 primary_doc.xml X0708 D LIVE 0001680378 SenesTech, Inc. 23460 N 19TH AVE, SUITE 110 PHOENIX AZ ARIZONA 85027 928-779-4143 DELAWARE None None Corporation true 2015 Kenneth Siegel 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Executive Officer Director Chief Executive Officer Thomas C Chesterman 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Executive Officer Chief Financial Officer Jamie Bechtel, JD, Ph.D. 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Delphine Francois Chiavarini 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Marc Dumont 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Matthew Szot 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Julie Williams, MD 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Biotechnology Decline to Disclose 06b false 2020-03-06 false true true true false 0 H.C. Wainwright & Co. 375 None None 430 PARK AVE NEW YORK NY NEW YORK 10022 All States false 579686 579686 0 The amount sold includes the purchase amount of the warrants issued to investors and the warrants issued to H.C. Wainwright & Co., the placement agent of the private placement. false 5 49750 5300 In connection with the registered direct offering of the Company's common stock concurrent with the private placement of warrants, the Company paid H.C. Wainwright & Co., as placement agent, a cash fee of $49,749.84 and a management fee of $5,299.98. 0 false SenesTech, Inc. /s/ Thomas C. Chesterman Thomas C. Chesterman Chief Financial Officer 2020-03-23